Bring Remdesivir under drug price control: Maha Barrister
Fri, Apr 16 2021 8:21 IST |
5 Views
Mumbai, April 16 : A prominent Maharashtra legal luminary has petitioned the Centre to declare the Remdesivir medicine - currently in huge demand owing to the Covid-19 pandemic - as a life-saving medicine with controlled pricing to prevent blackmarketing and corruption.
Remdesivir is manufactured by a handful of companies under brand names like Cipremi (Cipla), Covifar (Hetero), Desrem (Mylon), Remdac (Zydus), Redyx (Dr. Reddy s).
In a plea to the Central Government which controls the National Pharmaceutical Pricing Authority (NPPA), a statutory authority under the Drugs Price Control Order (DPCO), Mumbai Barrister Vinod Tiwari on Thursday demanded a high-level investigation into the artificial scarcity, hoarding, blackmarketing and misuse of the drug which could run into a racket of over Rs 25,000-crore under the nose of the NPPA, in the past ten months since the drug
COVID-19: Want to check availability of Remdesivir, hospital beds in India? Visit THESE websites
The anti-viral drug Remdesivir is considered a key drug in the fight against COVID-19, especially in adult patients with severe complications.
Share
Updated: Apr 16, 2021, 09:45 PM IST
Amid the sudden surge in COVID-19 cases across the country, several states have witnessed shortage of the anti-viral drug Remdesivir.
The anti-viral drug Remdesivir is considered a key drug in the fight against COVID-19, especially in adult patients with severe complications.
Remdesivir helps shorten recovery time for patients hospitalised with coronavirus disease and is being used in combination with other drugs in the treatment of COVID-19 symptoms.
Bring life-saver Remdesivir under drug price control: Maha Barrister prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.